NEW YORK, Feb. 22, 2016 -- Pomerantz LLP announces that a class action lawsuit has been filed against The Boeing Company (“Boeing” or the “Company”) (NYSE:BA) and certain of its officers. The class action, filed in United States District Court, Northern District of Illinois, and docketed under 16-cv-02454, is on behalf of a class consisting of all persons or entities who purchased Boeing securities between February 9, 2012 and February 11, 2016 inclusive (the “Class Period”). This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).
If you are a shareholder who purchased Boeing securities during the Class Period, you have until April 22, 2016 to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll free, ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and number of shares purchased.
Boeing, together with its subsidiaries, designs, develops, manufactures, sells, services, and supports commercial jetliners, military aircraft, satellites, missile defense, human space flight, and launch systems and services worldwide. The Company operates in five principal segments: Commercial Airplanes, Boeing Military Aircraft, Network & Space Systems, Global Services & Support, and Boeing Capital.
The Complaint alleges that throughout the Class Period, defendants made materially false and misleading statements regarding the Company’s business, operational and compliance policies. Specifically, defendants made false and/or misleading statements and/or failed to disclose that: (i) Boeing’s use of program accounting for the Company’s 787 Dreamliner and/or 747 jumbo aircrafts relied on inflated sales forecasts; (ii) Boeing’s use of program accounting for the Company’s 787 Dreamliner and/or 747 jumbo aircrafts relied on understated estimates of production costs; and (iii) as a result of the foregoing, Boeing’s public statements were materially false and misleading at all relevant times.
On February 11, 2016, Bloomberg News reported that the SEC is investigating whether Boeing properly accounted for the costs and expected sales of its 787 Dreamliner and 747 jumbo aircraft.
On this news, Boeing shares fell $7.92, or 6.8%, to close at $108.44 on February 11, 2016.
The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com
CONTACT: Robert S. Willoughby Pomerantz LLP [email protected]


U.S. Demand for Alternative Satellite Providers Remains Strong Amid SpaceX Regulatory Push
Strait of Hormuz Shipping Crisis Deepens as Traffic Plunges Amid Iran-U.S. Tensions
China’s Ultra-Cheap EV Boom: Why Electric Cars Cost Far Less Than in the U.S.
U.S. Sanctions Target Chinese Refinery Over Iranian Oil Purchases
Air Liquide Q1 Revenue Misses Estimates Amid Currency and Energy Headwinds
Micro Systemation Reports Q1 Loss Amid Strategic Investments and Revenue Growth
Nippon Express Stock Jumps as Elliott Investment Signals Strong Foreign Interest in Japan Logistics Sector
WuXi AppTec Stock Surges on Strong Q1 Earnings and CRDMO Demand Growth
Taiwan Court Fines Tokyo Electron Unit $4.78M in Major TSMC Trade Secrets Case
Spirit Airlines Gains Key Creditor Support for $500M Bailout Deal
SMC Corp Stock Surges as Palliser Capital Pushes for Major Share Buyback
Novartis Q1 2026 Earnings Miss Expectations as Generic Competition Pressures Sales
U.S. Budget Airlines Seek $2.5 Billion Government Aid Amid Rising Jet Fuel Costs
Brazil Pension Fund Crackdown After Banco Master Collapse Raises Investment Concerns
U.S. Warns Allies Over Alleged Chinese AI IP Theft Linked to DeepSeek
Sun Pharma to Acquire Organon in $11.75 Billion Deal to Boost Global Women’s Health Portfolio 



